Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

NCT05819866 ·Status: RECRUITING ·Phase: PHASE3

CARE Canadian ALS Riluzole Evaluation

NCT00542412 ·Status: COMPLETED ·Phase: PHASE4

A Study of Lu AF82422 in Participants With Multiple System Atrophy

NCT05104476 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)

NCT05107349 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

NCT05548556 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Determining the Safety of L-serine in ALS

NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)

NCT04956289 ·Status: COMPLETED ·Phase: PHASE2

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

NCT04749433 ·Status: TERMINATED ·Phase: PHASE1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

NCT05003921 ·Status: SUSPENDED ·Phase: PHASE1

Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders

NCT05474235 ·Status: RECRUITING

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

NCT05650229 ·Status: RECRUITING ·Phase: PHASE2

Study of SPG302 in Healthy Volunteers and ALS Participants

NCT05882695 ·Status: COMPLETED ·Phase: PHASE1

Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

NCT03792490 ·Status: COMPLETED ·Phase: PHASE2

Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis

NCT03085706 ·Status: COMPLETED ·Phase: NA

Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

NCT01480245 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

NCT04768062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis

NCT02479802 ·Status: COMPLETED ·Phase: PHASE2

Feasibility Study on LITT for Medical Refractory Epilepsy

NCT02820740 ·Status: TERMINATED ·Phase: NA

Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

NCT04004065 ·Status: TERMINATED ·Phase: PHASE2

Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients

NCT02424669 ·Status: UNKNOWN ·Phase: NA

Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis

NCT04518540 ·Status: UNKNOWN ·Phase: NA

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00445172 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype

NCT01823380 ·Status: COMPLETED ·Phase: NA

Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)

NCT01247207 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

NCT03334786 ·Status: TERMINATED ·Phase: PHASE1/PHASE2